Liquidia Corp. (LQDA)
58.12
+2.91
(+5.27%)
USD |
NASDAQ |
Nov 12, 16:00
57.73
-0.39
(-0.67%)
After-Hours: 06:50
Liquidia EPS Diluted (Quarterly) : -2.640 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.640 |
| June 30, 2026 | 0.7369 |
| March 31, 2026 | 0.5228 |
| December 31, 2025 | 0.1455 |
| September 30, 2025 | -0.0409 |
| June 30, 2025 | -0.4858 |
| March 31, 2025 | -0.4505 |
| December 31, 2024 | -0.4547 |
| September 30, 2024 | -0.3962 |
| June 30, 2024 | -0.3751 |
| March 31, 2024 | -0.399 |
| December 31, 2023 | -0.4196 |
| September 30, 2023 | -0.2435 |
| June 30, 2023 | -0.363 |
| March 31, 2023 | -0.1816 |
| December 31, 2022 | -0.1013 |
| September 30, 2022 | -0.141 |
| June 30, 2022 | -0.1519 |
| March 31, 2022 | -0.3039 |
| December 31, 2021 | -0.2211 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1398 |
| June 30, 2021 | -0.1288 |
| March 31, 2021 | -0.2114 |
| December 31, 2020 | -0.3804 |
| September 30, 2020 | -0.3965 |
| June 30, 2020 | -0.4886 |
| March 31, 2020 | -0.5203 |
| December 31, 2019 | -0.7119 |
| September 30, 2019 | -0.7156 |
| June 30, 2019 | -0.3147 |
| March 31, 2019 | -0.8584 |
| December 31, 2018 | -0.6172 |
| September 30, 2018 | -0.8334 |
| June 30, 2018 | -0.5857 |
| March 31, 2018 | -1.741 |
| December 31, 2017 | 0.5197 |
| September 30, 2017 | -34.91 |
| June 30, 2017 | -0.5249 |
| March 31, 2017 | -0.6227 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Therapeutics Corp. | 5.709 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
| Pfizer Inc. | 0.5637 |
| Amneal Pharmaceuticals, Inc. | -0.0646 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -236.33M |
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 461.63M |
| Enterprise Value | 4.988B |
| Gross Profit Margin (Quarterly) | 93.33% |
| Profit Margin (Quarterly) | -104.9% |
| Earnings Yield | -2.12% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 3.119 |